Roche acquired a portfolio of experimental cystic fibrosis therapies, including a candidate that has the potential to treat all patients with the disease.
https://www.pharmalive.com/wp-content/uploads/2020/10/Roche-Carves-Way-into-CF-Space-with-Portfolio-Acquisition-BioSpace-10-7-20.jpeg350625Andrew Humphreyshttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngAndrew Humphreys2020-10-07 12:05:132020-10-07 12:37:56Roche Carves Way into CF Space with Portfolio Acquisition